Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Rubin Tuder to Lung Neoplasms

This is a "connection" page, showing publications Rubin Tuder has written about Lung Neoplasms.

 
Connection Strength
 
 
 
0.197
 
  1. Winn RA, Tuder RM. "Un-slugging" resistance to epidermal growth factor receptor inhibition. A positive outlook for the future of lung cancer therapy. Am J Respir Crit Care Med. 2011 Apr 15; 183(8):970-2.
    View in: PubMed
    Score: 0.137
  2. Voelkel NF, Vandivier RW, Tuder RM. Vascular endothelial growth factor in the lung. Am J Physiol Lung Cell Mol Physiol. 2006 Feb; 290(2):L209-21.
    View in: PubMed
    Score: 0.024
  3. Tuder RM, Naves JM. [Mixed small and large cell undifferentiated carcinoma of the lung]. Rev Hosp Clin Fac Med Sao Paulo. 1984 Mar-Apr; 39(2):88-91.
    View in: PubMed
    Score: 0.021
  4. Donnelly TJ, Tuder RM, Vendegna TR. A 48-year-old woman with peripheral neuropathy, hypercalcemia, and pulmonary infiltrates. Chest. 1998 Oct; 114(4):1205-9.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)